These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 2005406)
1. Mechanism of nonresponsiveness to AKR/Gross leukemia virus in AKR.H-2b:Fv-1b mice. An analysis of precursor cytotoxic T lymphocyte frequencies in young versus moderately aged mice. Wegmann KW; McMaster JS; Green WR J Immunol; 1991 Apr; 146(7):2469-77. PubMed ID: 2005406 [TBL] [Abstract][Full Text] [Related]
3. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype. Green WR J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410 [TBL] [Abstract][Full Text] [Related]
4. Induction of anti-AKR/gross virus cytolytic T lymphocytes in AKR.H-2b:Fv-1b congenic mice: age-dependent conversion to a nonresponder phenotype. Green WR J Immunol; 1987 Mar; 138(5):1602-6. PubMed ID: 3027182 [TBL] [Abstract][Full Text] [Related]
5. A shift in the requirement for CD4+ T cells in the generation of AKR/Gross MuLV-specific CTL in AKR.H-2b:Fv-1b mice occurs prior to the onset of age-dependent CTL nonresponsiveness. Smith PM; Rich RF; Green WR Cell Immunol; 1997 Feb; 175(2):189-98. PubMed ID: 9023425 [TBL] [Abstract][Full Text] [Related]
6. Generation of anti-AKR/gross murine leukemia virus cytotoxic T lymphocytes (CTL). An analysis of precursor CTL frequencies in the AKR.H-2b and C57BL/6 mouse strains. Wegmann KW; Rich RF; Green WR J Immunol; 1992 Sep; 149(5):1593-8. PubMed ID: 1324278 [TBL] [Abstract][Full Text] [Related]
7. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells. Green WR J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998 [TBL] [Abstract][Full Text] [Related]
8. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control. Green WR J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409 [TBL] [Abstract][Full Text] [Related]
9. Expression of CTL-defined, AKR/Gross retrovirus-associated tumor antigens by normal spleen cells: control by Fv-1, H-2, and proviral genes and effect on antiviral CTL generation. Green WR J Immunol; 1986 Jan; 136(1):308-12. PubMed ID: 2999246 [TBL] [Abstract][Full Text] [Related]
10. Induction of anti-MuLV cytotoxic T lymphocytes in the AKR.H-2b and AKR.H-2b:Fv-1b mouse strains. Wegmann KW; Blank KJ; Green WR Cell Immunol; 1988 May; 113(2):308-19. PubMed ID: 2834071 [TBL] [Abstract][Full Text] [Related]
11. Clonal heterogeneity of anti-AKR/gross leukemia virus cytotoxic T lymphocytes. Evidence for two distinct antigen systems. Azuma H; Phillips JD; Green WR J Immunol; 1987 Oct; 139(7):2464-73. PubMed ID: 2821116 [TBL] [Abstract][Full Text] [Related]
12. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors. Manjunath R; Graziano RF; Green WR J Immunol; 1986 Mar; 136(6):2271-9. PubMed ID: 3005407 [TBL] [Abstract][Full Text] [Related]
13. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. I. Isolation of a selectively resistant variant tumor subclone. Green WR Eur J Immunol; 1983 Nov; 13(11):863-70. PubMed ID: 6196206 [TBL] [Abstract][Full Text] [Related]
14. Nonresponsiveness of AKR.H-2b congenic mice for anti-AKR/Gross MuLV CTL responses: involvement of inhibitory cells as defined by adoptive transfer experiments. Rich RF; Green WR Cell Immunol; 1995 Jan; 160(1):139-51. PubMed ID: 7842479 [TBL] [Abstract][Full Text] [Related]
15. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. II. Altered gp70 display and production of noninfectious virus particles by an insusceptible variant tumor. Green WR; Brown MA Eur J Immunol; 1983 Nov; 13(11):871-7. PubMed ID: 6196207 [TBL] [Abstract][Full Text] [Related]
16. Correlations of in vivo growth of CTL-susceptible and -resistant variant tumor cell lines in CTL-responder AKR.H-2b:Fv-1b and -nonresponder AKR.H-2b mice. Azuma H; Wegmann KW; Green WR Cell Immunol; 1988 Oct; 116(1):123-34. PubMed ID: 3262427 [TBL] [Abstract][Full Text] [Related]
17. Resistance to cellular immune response in AKR leukemias. Schäfer A; Schmidt W Eur J Immunol; 1986 Jul; 16(7):753-9. PubMed ID: 2424771 [TBL] [Abstract][Full Text] [Related]
18. Spontaneous in vivo retrovirus-infected T and B cells, but not dendritic cells, mediate antigen-specific Fas ligand/Fas-dependent apoptosis of anti-retroviral CTL. Rich RF; Cook WJ; Green WR Virology; 2006 Mar; 346(2):287-300. PubMed ID: 16337984 [TBL] [Abstract][Full Text] [Related]
19. AKR.H-2b lymphocytes inhibit the secondary in vitro cytotoxic T-lymphocyte response of primed responder cells to AKR/Gross murine leukemia virus-induced tumor cell stimulation. Rich RF; Green WR J Virol; 1996 Jan; 70(1):402-14. PubMed ID: 8523554 [TBL] [Abstract][Full Text] [Related]
20. Lymphomagenesis in AKR.Fv-1b congenic mice. Haran-Ghera N; Peled A; Brightman BK; Fan H Cancer Res; 1993 Jul; 53(14):3433-8. PubMed ID: 8324753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]